It belongs to a drug group called antispasmodics and acts as a calcium channel blocker in helping to restore the normal contraction process of the bowel.

It is most effective when taken for a full course of treatment and is not designed for immediate symptom relief or sporadic, intermittent use.

[1] Pinaverium bromide was first registered in 1975 by Solvay Pharmaceuticals (now a division of Abbott Laboratories), and marketed globally using the brand names Dicetel and Eldicet.

Generic pinaverium is available in South Korea under a trade name of Disten[2] and in Argentina as Nulite.

[3] It is indicated for the treatment and relief of symptoms associated with irritable bowel syndrome (IBS) including abdominal pain, bowel disturbances and intestinal discomfort; and treatment of symptoms related to functional disorders of biliary tract.